Abstract:Synaptotagmin-1 (Syt1) is a presynaptic calcium sensor with two calcium binding domains, C2A and C2B, that triggers action potential-induced synchronous neurotransmitter release, while suppressing asynchronous and spontaneous release. We identified a de novo missense mutation (P401L) in the C2B domain in a patient with developmental delay and autistic symptoms. Expressing the orthologous mouse mutant (P400L) in cultured Syt1 null mutant neurons revealed a reduction in dendrite outgrowth with a proportional reduction in synapses. This was not observed in single Syt1 PL -rescued neurons that received normal synaptic input when cultured in a control network. Patch-clamp recordings showed that spontaneous miniature release events per synapse were increased more than 500% in Syt1 PL -rescued neurons, even beyond the increased rates in Syt1 KO neurons. Furthermore, action potential-induced asynchronous release was increased more than 100%, while synchronous release was unaffected. A similar shift to more asynchronous release was observed during train stimulations. These cellular phenotypes were also observed when Syt1 PL was overexpressed in wild type neurons. Our findings show that Syt1 PL desynchronizes neurotransmission by increasing the readily releasable pool for asynchronous release and reducing the suppression of spontaneous and asynchronous release. Neurons respond to this by shortening their dendrites, possibly to counteract the increased synaptic input. Syt1 PL acts in a dominant-negative manner supporting a causative role for the mutation in the heterozygous patient. We propose that the substitution of a rigid proline to a more flexible leucine at the bottom of the C2B domain impairs clamping of release by interfering with Syt1's primary interface with the SNARE complex. This is a novel cellular phenotype, distinct from what was previously found for other SYT1 disease variants, and points to a role for spontaneous and asynchronous release in SYT1 -associated neurodevelopmental disorder.

Synaptotagmin-7 Deficiency Induces Mania-Like Behavioral Abnormalities Through Attenuating GluN2B Activity

Synaptotagmin-7–mediated activation of spontaneous NMDAR currents is disrupted in bipolar disorder susceptibility variants

Synaptotagmin-7 is a Key Factor for Bipolar-Like Behavioral Abnormalities in Mice

Deficiency of Shank2 Causes Mania-Like Behavior That Responds to Mood Stabilizers.

Synaptotagmin-11 Deficiency Mediates Schizophrenia-Like Behaviors in Mice Via Dopamine Over-Transmission

Disrupting phosphorylation of Tyr-1070 at GluN2B selectively produces resilience to depression-like behaviors

Synaptotagmin-7 Counteracts Short-Term Depression during Phasic Dopamine Release

Chrna7 deficient mice manifest no consistent neuropsychiatric and behavioral phenotypes

Modulation of Synaptic Plasticity by Antimanic Agents: the Role of AMPA Glutamate Receptor Subunit 1 Synaptic Expression.

Pharmacological intervention in young adolescents rescues synaptic physiology and behavioural deficits in Syngap1+/− mice

SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties

Altered GluA1 (Gria1) Function and Accumbal Synaptic Plasticity in the ClockΔ19 Model of Bipolar Mania

A bipolar disorder-associated missense variant alters adenylyl cyclase 2 activity and promotes mania-like behavior

P2X7 receptor inhibition alleviates mania-like behaviour independently of IL-1β

A de novo missense mutation in synaptotagmin-1 associated with neurodevelopmental disorder desynchronizes neurotransmitter release

Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1- related intellectual disability

Utilizing systematic Mendelian randomization to identify potential therapeutic targets for mania

Early correction of synaptic long-term depression improves abnormal anxiety-like behavior in adult GluN2B-C456Y-mutant mice

Hypermethylation induced by L-methionine leads myelin breakdown and schizophrenia-like behavior in adolescent mice

Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP61

NEK4 modulates circadian fluctuations of emotional behaviors and synaptogenesis in male mice